288 related articles for article (PubMed ID: 18585916)
1. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code.
Calao M; Burny A; Quivy V; Dekoninck A; Van Lint C
Trends Biochem Sci; 2008 Jul; 33(7):339-49. PubMed ID: 18585916
[TBL] [Abstract][Full Text] [Related]
2. Regulation of NF-kappaB action by reversible acetylation.
Greene WC; Chen LF
Novartis Found Symp; 2004; 259():208-17; discussion 218-25. PubMed ID: 15171256
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells.
Ho WC; Dickson KM; Barker PA
Cancer Res; 2005 May; 65(10):4273-81. PubMed ID: 15899819
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer.
Chavey C; Mühlbauer M; Bossard C; Freund A; Durand S; Jorgensen C; Jobin C; Lazennec G
Mol Pharmacol; 2008 Nov; 74(5):1359-66. PubMed ID: 18669446
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
Spange S; Wagner T; Heinzel T; Krämer OH
Int J Biochem Cell Biol; 2009 Jan; 41(1):185-98. PubMed ID: 18804549
[TBL] [Abstract][Full Text] [Related]
6. Impact of post-translational modifications of proteins on the inflammatory process.
Ito K
Biochem Soc Trans; 2007 Apr; 35(Pt 2):281-3. PubMed ID: 17371260
[TBL] [Abstract][Full Text] [Related]
7. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
Araki K; Kawauchi K; Tanaka N
Oncogene; 2008 Sep; 27(43):5696-705. PubMed ID: 18542057
[TBL] [Abstract][Full Text] [Related]
8. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
Scheidereit C
Oncogene; 2006 Oct; 25(51):6685-705. PubMed ID: 17072322
[TBL] [Abstract][Full Text] [Related]
9. Advances in NF-kappaB signaling transduction and transcription.
Xiao W
Cell Mol Immunol; 2004 Dec; 1(6):425-35. PubMed ID: 16293211
[TBL] [Abstract][Full Text] [Related]
10. Assessing acetylation of NF-kappaB.
Chen LF; Greene WC
Methods; 2005 Aug; 36(4):368-75. PubMed ID: 16111893
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation via the NF-kappaB signaling module.
Hoffmann A; Natoli G; Ghosh G
Oncogene; 2006 Oct; 25(51):6706-16. PubMed ID: 17072323
[TBL] [Abstract][Full Text] [Related]
12. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression.
Rahman I; Marwick J; Kirkham P
Biochem Pharmacol; 2004 Sep; 68(6):1255-67. PubMed ID: 15313424
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes.
Shaw J; Zhang T; Rzeszutek M; Yurkova N; Baetz D; Davie JR; Kirshenbaum LA
Circ Res; 2006 Dec; 99(12):1347-54. PubMed ID: 17082476
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells.
Lindström TM; Mohan AR; Johnson MR; Bennett PR
Mol Pharmacol; 2008 Jul; 74(1):109-21. PubMed ID: 18375836
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
[TBL] [Abstract][Full Text] [Related]
16. [Cellular aspects of regulation of nuclear factor kappaB (NF-kappabeta) transcriptional activity in sensory neurons in vitro].
Gushchina SV; Volkova OV; Krugliakov PP; Magoulas KB
Morfologiia; 2010; 137(3):22-6. PubMed ID: 20960709
[TBL] [Abstract][Full Text] [Related]
17. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
Perkins ND
Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
[TBL] [Abstract][Full Text] [Related]
18. Cell signaling. Stat acetylation--a key facet of cytokine signaling?
O'Shea JJ; Kanno Y; Chen X; Levy DE
Science; 2005 Jan; 307(5707):217-8. PubMed ID: 15653493
[No Abstract] [Full Text] [Related]
19. Histone acetyltransferase HBO1 inhibits NF-kappaB activity by coactivator sequestration.
Contzler R; Regamey A; Favre B; Roger T; Hohl D; Huber M
Biochem Biophys Res Commun; 2006 Nov; 350(1):208-13. PubMed ID: 16997280
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.
Sebban H; Yamaoka S; Courtois G
Trends Cell Biol; 2006 Nov; 16(11):569-77. PubMed ID: 16987664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
